FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

373542000: Methyldopa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1198842010 Methyldopa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1212009011 Methyldopa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1198842010 Methyldopa (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1198842010 Methyldopa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1212009011 Methyldopa en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1212009011 Methyldopa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2692200017 Methyldopa anhydrous en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2692200017 Methyldopa anhydrous en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
364131000195117 metildopa it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
824871000172111 méthyldopa fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
824871000172111 méthyldopa fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
364131000195117 metildopa it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methyldopa (substance) Is a Alpha-2 adrenergic receptor agonist false Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa (substance) Is a Substance with central alpha adrenergic receptor agonist mechanism of action false Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa (substance) Has disposition Alpha-2 adrenergic receptor agonist (disposition) false Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa (substance) Is a Alpha amino acid false Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa (substance) Is a Amine and/or amine derivative true Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa (substance) Is a Substance with central alpha-2 adrenergic receptor agonist mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa (substance) Has disposition Central alpha-2 adrenergic receptor agonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Methyldopate hydrochloride (substance) Is a False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa measurement Component True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa adverse reaction Causative agent (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa and diuretic adverse reaction Causative agent (attribute) False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Methyldopa allergy Causative agent (attribute) False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Allergy to methyldopa and diuretic Causative agent (attribute) False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa 125 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa 250 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa+diuretic The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Chlorothiazide 250 mg and methyldopa 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide + methyldopa 15mg/250mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Chlorothiazide- and methyldopa-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing hydrochlorothiazide and methyldopa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa allergy Causative agent (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Allergy to methyldopa and diuretic Causative agent (attribute) False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Cirrhosis of liver caused by methyldopa (disorder) Causative agent (attribute) False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Methyldopa 125 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa 125 mg oral tablet Has basis of strength substance (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa 250 mg oral tablet Has basis of strength substance (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa 500 mg oral tablet Has basis of strength substance (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa 250 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa 250 mg oral capsule Has basis of strength substance (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Chlorothiazide 250 mg and methyldopa 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Chlorothiazide 250 mg and methyldopa 250 mg oral tablet Has basis of strength substance (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet Has basis of strength substance (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet Has basis of strength substance (attribute) False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has basis of strength substance (attribute) False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet Has basis of strength substance (attribute) False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet Has basis of strength substance (attribute) False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has basis of strength substance (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet Has basis of strength substance (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Chlorothiazide 250 mg and methyldopa 250 mg oral tablet Has precise active ingredient True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Methyldopa 125 mg oral tablet Has precise active ingredient True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa 250 mg oral tablet Has precise active ingredient True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa 500 mg oral tablet Has precise active ingredient True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa 250 mg oral capsule Has precise active ingredient True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing chlorothiazide and methyldopa in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has precise active ingredient True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet Has precise active ingredient False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet Has precise active ingredient False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet Has precise active ingredient False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing hydrochlorothiazide and methyldopa in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Chlorothiazide and methyldopa only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only hydrochlorothiazide and methyldopa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only methyldopa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only methyldopa in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Chlorothiazide and methyldopa only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide and methyldopa only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa anhydrous Is modification of (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopate Is a False Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Cirrhosis of liver caused by methyldopa (disorder) Causative agent (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Cirrhosis of liver caused by methyldopa (disorder) Causative agent (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet Has precise active ingredient True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet Has precise active ingredient True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet Has precise active ingredient True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet Has basis of strength substance (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Methyldopa sesquihydrate (substance) Is modification of (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopate Is modification of (attribute) True Methyldopa (substance) Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start